Tompkins Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$497K Hold
2,200
– – 0.04% 132
2026
Q2
$475K Buy
+2,200
New +$421K 0.03% 134
2025
Q2
– Sell
-81
Closed -$11.1K – 551
2025
Q1
$11.1K Hold
81
– – ﹤0.01% 441
2024
Q4
$12.4K Hold
81
– – ﹤0.01% 420
2024
Q3
$15.7K Hold
81
– – ﹤0.01% 437
2024
Q2
$18.8K Hold
81
– – ﹤0.01% 441
2024
Q1
$17.5K Hold
81
– – ﹤0.01% 450
2023
Q4
$21K Hold
81
– – ﹤0.01% 420
2023
Q3
$20.8K Buy
+81
New +$21.7K ﹤0.01% 404
2016
Q3
– Sell
-43
Closed -$10K – 394
2016
Q2
$10K Hold
43
– – ﹤0.01% 392
2016
Q1
$11K Buy
+43
New +$11.4K ﹤0.01% 374
2015
Q4
– Sell
-88
Closed -$26K – 511
2015
Q3
$26K Sell
88
-91
-51% -$30.1K 0.01% 347
2015
Q2
$73K Sell
179
-32
-15% -$12.8K 0.02% 226
2015
Q1
$89K Buy
211
+179
+559% +$70.6K 0.02% 221
2014
Q4
$11K Hold
32
– – ﹤0.01% 371
2014
Q3
$11K Sell
32
-5
-14% -$1.65K ﹤0.01% 368
2014
Q2
$12K Hold
37
– – ﹤0.01% 366
2014
Q1
$11K Buy
37
+5
+16% +$1.59K ﹤0.01% 378
2013
Q4
$9K Buy
+32
New +$8.28K ﹤0.01% 416

Other funds holding BIIB

Tompkins Financial's BIIB Position: Q3 2026 in Review

Tompkins Financial held its Biogen (BIIB) position steady in Q3 2026 at 2,200 shares worth $497K. The position accounts for 0.04% of the portfolio, ranked #132.

Tompkins Financial first reported a position in BIIB in Q4 2013 and has held it in 19 quarters since. 126 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Tompkins Financial held 2,200 shares of Biogen worth $497K as of Q3 2026.
  • Tompkins Financial left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.04% of Tompkins Financial's portfolio in Q3 2026, its #132 holding.
  • Tompkins Financial first reported a position in Biogen in Q4 2013 and has held it in 19 quarters since.
  • 126 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Tompkins Financial's 13F filing for Q3 2026, filed 5 Oct 2026.